MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Brain De-Ironization with Nasal Spray of Iron Chelator in Treatment of Multiple System Atrophy, a Case Trial

    A. Amoushahi, A. Sahebkar, P. Moeini, N. Chitsaz (Isfahan, Islamic Republic of Iran)

    Objective: Iron removal seems to be a treatment approach in Multiple system atrophy (MSA) because pathological findings shows the accumulation of iron and α-synuclein protein…
  • 2024 International Congress

    Unsupervised Learning Approach for Pathology-Based Subtyping and Staging Multiple System Atrophy

    H. Sekiya, D. Ono, D. Dickson (Jacksonville, USA)

    Objective: To develop a classification and staging system for multiple system atrophy (MSA) using data-driven disease progression modeling. Background: MSA exhibits varying degrees of degeneration…
  • 2024 International Congress

    Familial Multiple System Atrophy-Mimics: Importance of Comprehensive Evaluation

    CH. Jeong, HJ. Kim (Seoul, Republic of Korea)

    Objective: We present two patients initially diagnosed as familial MSA until one of the patients was proven to be metachromatic leukodystrophy (MLD). Background: Multiple system…
  • 2024 International Congress

    Environmental risk factors and demographic of patients with Progressive Supranuclear Palsy from Argentina

    F. Rellan, B. Couto, F. Gonzalez Del-Boca, M. Paez Magio, C. Villa, E. Franchello, G. Alvarado, G. Mizraji, D. Nadile, C. Tanner, O. Gershanik, C. Marras (Buenos Aires, Argentina)

    Objective: To describe the environmental risk factors and family history in Argentinian patients with diagnosis of progressive supranuclear palsy (PSP). Background: Background: The current epidemiology…
  • 2024 International Congress

    Neuropsychiatric symptoms in patients with probable Progressive supranuclear palsy in reference centers of Valle del Cauca- Colombia

    V. Martínez-Villota, L. Ortega-Bolaños, C. Hurtado-Gonzalez (Pasto, Colombia)

    Objective: To evaluate the neuropsychiatric symptoms in patients with probable Progressive supranuclear palsy attended in reference centers  of the Valle del Cauca, Colombia, between 2020 and…
  • 2024 International Congress

    Association between use of Furosemide and Risk of Parkinson’s disease

    B. Babar, AM. Tolppanen, S. Hartikainen, M. Tiihonen (Kuopio, Finland)

    Objective: Main objective of study is to check the association between furosemide use and risk of Parkinson's disease (PD) in a Finnish nationwide nested case-control…
  • 2024 International Congress

    Cardiovascular Associations of Cortical Lewy Bodies in the Oldest Old: The 90+ study

    R. Rajmohan, Z. Al-Darsani, N. Phielipp, T. Montine, M. Corrada, C. Kawas (Orange, USA)

    Objective: To identify potential risk factors for cortical Lewy Bodies (CLB) in the oldest-old (> 90 years old), we investigated if cardiovascular medical histories, medication…
  • 2024 International Congress

    Cholinergic Brain Signature of Presbyvestibulopathy in Parkinson’s Disease: Exploring Central Nervous System Vestibular Mechanisms

    P. Kanel, G. Carli, T. Brown, S. David, R. Vangel, C. Pongmala, D. Mccaslin, K. Kerber, N. Bohnen (Ann Arbor, USA)

    Objective: To investigate topographic cholinergic brain differences between Parkinson's disease (PD) patients with and without presbyvestibulopathy (PVP). Background: Age-associated vestibulopathy (PVP) is commonly observed in…
  • 2024 International Congress

    A Case of Concurrent Wilson Disease and Parkinson Disease

    C. Tapia, M. Davis, M. Penon-Portmann, S. Hahn, E. Rezvanian (Seattle, USA)

    Objective: to present a case of concurrent Wilson disease and Parkinson disease. Background: Wilson disease (WD) is a rare autosomal recessive disease that typically manifests…
  • 2024 International Congress

    New onset movement disorders following COVID-19 infection

    D. van Wamelen, B. Facer, S. Rota, M. Bonello, K. Chaudhuri, G. Breen, B. Michael (London, United Kingdom)

    Objective: To determine the prevalence and phenotype of movement disorders following SARS-CoV-2 infection in hospitalised individuals. Background: Although movement disorders, including parkinsonism, following SARS-CoV-2 (COVID-19)…
  • 1
  • 2
  • 3
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley